助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[2]页 共[31]条 当前为第1条到20条
 

相关语句
superficial bladder carcinoma
(Bacillus Calmette Guérin) has proven to be effective in the prophylaxis of recurrence of superficial bladder carcinoma after transurethral resection and in the treatment of carcinoma in situ (C.I.S.) in man.
      
The main problems presented by superficial bladder carcinoma, its high recurrence rate and multifocal appearance, require treatment of the bladder as a whole.
      
Photodynamic therapy (PDT) is one such experimental treatment for superficial bladder carcinoma, involving the administration of a photosensitizer that accumulates in the tumor tissue, and subsequent irradiation of the tumor with light.
      
The results show that ALA-induced photosensitization has a high potential for photodynamic therapy (PDT) of superficial bladder carcinoma.
      
In intravesical therapy for superficial bladder carcinoma urothelial cells may, through the production of cytokines, contribute to the bacillus Calmette-Guérin (BCG)-induced local immunological reaction and associated antitumor efficacy.
      
In conclusion, the present in vitro data suggest KW-2149 to be a superior drug for intravesical therapy of patients with primary or recurrent superficial bladder carcinoma.
      
Influence of pertussis toxin on superficial bladder carcinoma in rats
      
Early adjuvant Adriamycin in superficial bladder carcinoma
      
Single instillation of hydroxypropylcellulose-doxorubicin as treatment for superficial bladder carcinoma
      
A single instillation of hydroxypropylcellulose (HPC)-doxorubicin (20 mg/20 ml) was performed in 20 patients with superficial bladder carcinoma.
      
Combined intravesical instillation of HPC-doxorubicin and local hyperthermia using a Thermotron RF-8 was performed in 11 patients with recurrent superficial bladder carcinoma.
      
Therefore, the combination of intravesical instillation of HPC-doxorubicin and local hyperthermia was more effective against superficial bladder carcinoma than the single instillation of the chemotherapeutic agent alone.
      
Intravesical instillation of Bacillus Calmette-Guerin (BCG) is used with efficacy and safety in the treatment of patients with intermediate and high-risk superficial bladder carcinoma.
      
Early adjuvant adriamycin in superficial bladder carcinoma
      
With the exception of BCG, most forms of immunotherapy have not been been effective in the treatment of superficial bladder carcinoma.
      
Intravesical treatment of superficial bladder carcinoma with interferons
      
The high incidence of tumor recurrence and the multifocal occurrence of superficial bladder carcinoma have stimulated the idea of intracavitary treatment for therapy and prophylaxis.
      
In this study the efficacy of topical administration of IFN was investigated in 10 patients with recurrent superficial bladder carcinoma without evidence of local or distant metastases.
      
Biological potentials of interferons relevance in the systemic treatment of superficial bladder carcinoma
      
in the therapy of superficial bladder carcinoma, may offer more promising results in comparison to systemic application.
      
 

首页上一页12下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社